Our study further found that CUMS-induced depression and comorbid hyperglycemia activated IL-6 in the hypothalamus, suggesting that overactivation of innate IL-6 could play a crucial role in the pathogenesis of depression susceptibility to hyperglycemia, which is consistent with several previous reports. Here, IL6 is linked to depressive disorder.